| Measure | Time; % of physicians | Adjusted change, QIIP group v. control group (95% CI)* | ||
|---|---|---|---|---|
| 12 mo before intervention or index date | 12 mo after intervention or index date | |||
| Colorectal cancer | ||||
| Fecal occult blood testing within previous 2 yr | QIIP group | 41.1 | 52.2 | 8.5 (5.1 to 12.0) |
| Control group | 39.5 | 42.8 | ||
| Colonoscopy within previous 5 yr | QIIP group | 24.5 | 29.7 | 0.02 (-1.7 to 1.8) |
| Control group | 26.6 | 31.7 | ||
| Flexible sigmoidoscopy/barium enema | QIIP group | 5.8 | 3.8 | -0.03 (-0.1 to 0.3) |
| Control group | 6.3 | 4.4 | ||
| Any screening | QIIP group | 57.2 | 67.1 | 5.4 (3.1 to 7.8) |
| Control group | 57.6 | 62.4 | ||
| Cervical cancer | ||||
| Papanicolaou test within previous 2 yr | QIIP group | 61.7 | 63.5 | 2.3 (0.5 to 4.1) |
| Control group | 62.3 | 61.4 | ||
| Papanicolaou test within previous 3 yr | QIIP group | 72.2 | 75.1 | 2.7 (0.9 to 4.6) |
| Control group | 72.9 | 72.7 | ||
Note: CI = confidence interval, QIIP = Quality Improvement and Innovation Partnership.
*General linear regression for baseline value, sex, rurality, age and comorbidity (Johns Hopkins Adjusted Diagnosis Groups30).